MP Biomedicals completes its range of in vitro diagnostic tests for infectious diseases with new immunochromatographic-based qualitative rapid tests.The new diagnostic kits by MP Biomedicals leverage cutting-edge technology to deliver precise results, enabling healthcare professionals a rapid and accurate detection of Helicobacter pylori, Salmonella typhi and Vibrio cholerae serogroups O1 and O139.
FDA sets December approval decision for first CRISPR therapy, with 94% of patients free of sickle cell crises
Nearly 11 years ago, scientists programmed a pair of molecular scissors to make precise cuts in DNA. That first test tube experiment of CRISPR gene
June 9, 2023